ANDERA PARTNERS
13F Portfolio Filings
Most recent 13F
Q1 2026
Location
Paris, France
CIK
0001757283
All SEC filings
View on sec.gov
Holdings Value
Quarter
Holdings
Value ($000)
Top Holdings
Form Type
Date Filed
Filing ID
Q1 2026
7
176,916
KMTS, EVOMMUNE INC, MLYS, AGOMAB THERAPEUTICS NV
13F-HR
5/11/2026
000175728326000012
Q4 2025
5
176,607
KMTS, MLYS, EVOMMUNE INC, 2X10.SG
13F-HR
2/17/2026
000175728326000007